MINIMIZING ADVERSE EXPERIENCE ASSOCIATED WITH OXYBUTYNIN THERAPY - Patent 1280486

(19)

(11)

EP 1 280 486 A1

(12)

(43)	Date of publication:
	05.02.2003 Bulletin 2003/06

(21)	Application number: 01927318.4

(22)	Date of filing: 24.04.2001

(51)	International Patent Classification (IPC)⁷: A61F 13/00

(86)	International application number:
	PCT/US0113/135

(87)	International publication number:
	WO 0108/0796 (01.11.2001 Gazette 2001/44)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

26.04.2000 US 559711

(71)	Applicant: Watson Pharmaceuticals, Inc.
	Corona, CA 92880 (US)

(72)	Inventors:
	SANDERS, Steven, W. Salt Lake City, UT 84121 (US) EBERT, Charles, D. Salt Lake City, UT 84108 (US)

(74)	Representative: Thomson, Paul Anthony et al
	Potts, Kerr & Co.15, Hamilton Square BirkenheadMerseyside CH41 6BR BirkenheadMerseyside CH41 6BR (GB)

(54)	MINIMIZING ADVERSE EXPERIENCE ASSOCIATED WITH OXYBUTYNIN THERAPY